To evaluate the diagnostic utility, value and potential risk of fine needle
aspiration biopsy of spleen (sFNAB) in patients with splenomegaly in pyrex
ia of unknown origin (PUO), a retrospective analysis of medical records and
cytological material of 31 patients on whom FNAB was performed between Apr
il 1994 and October 1997 was done. The patients were HIV- and presented wit
h PUO. All other relevant investigations were negative. The spleen was eith
er palpable or detected to have space-occupying lesions on ultrasonography
(USG). The splenic aspirates showed tuberculosis in 11 patients (35.4%) and
inconclusive or reactive changes in nine patients (25.8%). One case out of
this group proved to be Kaposi's sarcoma on autopsy. The other diseases en
countered were leishmaniasis (n = 3), non-Hodgkin's lymphoma (n = 4), funga
l infections (n = 2), Hodgkin's lymphoma (n = 1). The patients who were dia
gnosed as having tuberculosis had epithelioid cells, giant cells, necrosis
and inflammatory cells in various combinations. AFB positivity was 63.6%. T
he other cases which showed granulomas but no AFB were diagnosed on empiric
al grounds and all responded to the anti-tuberculosis therapy. No complicat
ions were encountered with the procedure. Therefore the authors conclude th
at sFNAB is rewarding in patients where all other non-invasive modalities o
f diagnosis have failed.